New Drugs

Brand/Generic Company Description
Ajovy
fremanezumab
Teva

An injectable anti-calcitonin gene-related peptide for migraine prevention in adults.

Avsola
infliximab
Amgen

Biosimilar to Remicade.

Beovu
brolucizumab
Novartis

Intravitreal VEGF inhibitor for neovascular (wet) age-related macular degeneration.

Cabenuva
cabotegravir/rilpivirine
ViiV Healthcare

Extended-release injectable formulation for HIV-1 infection.

Cablivi
caplacizumab
Sanofi Genzyme

An injectable antithrombotic for acquired thrombotic thrombocytopenic purpura.

Daurismo
glasdegib
Pfizer

An oral Hedgehog pathway inhibitor for newly-diagnosed acute myeloid leukemia.

Enspryng
satralizumab
Hoffmann-La Roche

An injectable monoclonal antibody for neuromyelitis optica spectrum disorders.

Ibsrela
tenapanor
Knight Therapeutics

An oral sodium/hydrogen exchanger 3 (NHE3) inhibitor for IBS-C.

Itulatek
white birch allergen extract
Alk-Abello

SL allergy immunotherapy for moderate to severe seasonal allergic rhinitis induced by pollen from birch, alder, and/or hazel.

Kanjinti
trastuzumab
Amgen

Biosimilar to Herceptin.

Mayzent
siponimod
Novartis

An oral sphingosine 1-phosphate receptor modulator for multiple sclerosis.

Nivestym
filgrastim
Pfizer

A biosimilar to Neupogen.

Nubeqa
darolutamide
Bayer

An oral antiandrogen for non-metastatic castration resistant prostate cancer.

Odomzo
sonidegib
Sun Pharma

Oral hedgehog pathway inhibitor for basal cell carcinoma.

Osnuvo
teriparatide
Avir Pharma

A biosimilar to Forteo.

Piqray
alpelisib
Novartis

Oral kinase inhibitor for advanced/metastatic breast cancer.

Qinlock
ripretinib
Deciphera (US)

Oral kinase inhibitor for gastrointestinal stromal tumours.

Riximyo
rituximab
Sandoz

A biosimilar to Rituxan.

Rozlytrek
entrectinib
Hoffmann-La Roche

A tyrosine kinase inhibitor for advanced extracranial solid tumours, including brain metastases.

Ruxience
rituximab
Pfizer

A biosimilar to Rituxan.

Sarclisa
isatuximab
Sanofi-Aventis

A monoclonal antibody for refractory multiple myeloma.

Spravato
esketamine
Janssen

An intranasal NMDA antagonist for depression.

Tukysa
tucatinib
Seattle Genetics

An oral kinase inhibitor for advanced HER2-positive breast cancer.

Vocabria
cabotegravir
ViiV Healthcare

Oral formulation (used with oral rilpivirine) for short-term treatment of HIV-1 infection (used before starting Cabenuva to assess tolerability or as oral bridging therapy for missed Cabenuva injections).

Vyndaqel
tafamidis meglumine
Pfizer

An oral transthyretin stabilizer for cardiomyopathy due to transthyretin-mediated amyloidosis.

Xofluza
baloxavir marboxil
Hoffmann-La Roche

An oral antiviral for treating influenza.

Ziextenzo
pegfilgrastim
Sandoz

A biosimilar to Neulasta.

Brand/Generic Company Description
Atectura Breezhaler
indacaterol/mometasone
Novartis

A combination inhaled LABA/corticosteroid for maintenance treatment of asthma.

Duobrii
halobetasol/tazarotene
Bausch Health

New formulation corticosteroid/retinoid lotion for plaque psoriasis.

Enerzair Breezhaler
indacaterol/glycopyrronium/mometasone
Novartis

New combination long-acting bronchodilator/steroid inhaler for asthma maintenance therapy.

Kynmobi
apomorphine
Sunovion

Sublingual dopamine agonist for acute intermittent off episodes in Parkinson’s disease.

Nexplanon
etonogestrel
Merck

New subdermal implant formulation for contraception.

Peyona
caffeine citrate
Chiesi (Spain)

CNS stimulant for primary apnea in premature newborns.

Suvexx
sumatriptan/naproxen
Nuvo Pharm.

New oral triptan/NSAID combination for acute migraine.

Uceris
budesonide
Bausch Health

New rectal foam formulation for mild to moderate ulcerative colitis.

Brand/Generic Company Description